Pfizer says long-awaited Lyme vaccine was effective in study

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though ...

Lyme disease vaccine 70 percent effective: Pfizer

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed ...
Morning Overview on MSN

Pfizer and BioNTech pause US COVID vaccine trial after slow enrollment

Pfizer and BioNTech have paused a large U.S. clinical trial designed to test their updated COVID-19 vaccine in healthy adults ...

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...
pharmaphorum

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Valneva and Pfizer's three-dose shot targets the outer surface protein A (OspA) of the Borrelia burgdorfii bacteria that ...